US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 9.020
  • +0.050+0.56%
Close Nov 12 16:00 ET
  • 9.020
  • 0.0000.00%
Post 20:01 ET
176.18MMarket Cap-6115P/E (TTM)

Actuate Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.91%5.64M
50.48%7.97M
23.59%24.97M
5.58M
5.3M
20.21M
Selling and administrative expenses
56.43%1.26M
43.63%1.11M
-14.51%3.27M
--807.18K
--774.8K
--3.82M
-General and administrative expense
56.43%1.26M
43.63%1.11M
-14.51%3.27M
--807.18K
--774.8K
--3.82M
Research and development costs
-8.47%4.37M
51.65%6.86M
32.47%21.71M
--4.78M
--4.52M
--16.39M
Operating profit
-0.91%-5.64M
-50.48%-7.97M
-23.59%-24.97M
-5.58M
-5.3M
-20.21M
Net non-operating interest income expense
-96.77%3.57K
-58.14%9.71K
2,754.26%309.03K
110.33K
23.2K
10.83K
Non-operating interest income
-92.51%8.65K
-71.37%14.79K
1,204.89%352.67K
--115.39K
--51.65K
--27.03K
Non-operating interest expense
0.28%5.08K
-82.16%5.08K
169.39%43.64K
--5.06K
--28.45K
--16.2K
Other net income (expense)
-1,773.41%-940.34K
-6,614.79%-332.52K
-318.22%-79.82K
-50.19K
5.1K
36.58K
Gain on sale of security
-378.82%-240.34K
-737.05%-32.52K
-318.22%-79.82K
---50.19K
--5.1K
--36.58K
Other non- operating income (expenses)
---700K
---300K
----
----
----
----
Income before tax
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-5.52M
-5.27M
-20.16M
Income tax
Net income
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-5.52M
-5.27M
-20.16M
Net income continuous Operations
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
---5.52M
---5.27M
---20.16M
Minority interest income
Net income attributable to the parent company
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-5.52M
-5.27M
-20.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-5.52M
-5.27M
-20.16M
Basic earnings per share
3.58%-0.3439
-58.71%-0.54
-23.05%-1.65
-0.3566
-0.3402
-1.3409
Diluted earnings per share
3.58%-0.3439
-58.71%-0.54
-23.05%-1.65
-0.3566
-0.3402
-1.3409
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.91%5.64M50.48%7.97M23.59%24.97M5.58M5.3M20.21M
Selling and administrative expenses 56.43%1.26M43.63%1.11M-14.51%3.27M--807.18K--774.8K--3.82M
-General and administrative expense 56.43%1.26M43.63%1.11M-14.51%3.27M--807.18K--774.8K--3.82M
Research and development costs -8.47%4.37M51.65%6.86M32.47%21.71M--4.78M--4.52M--16.39M
Operating profit -0.91%-5.64M-50.48%-7.97M-23.59%-24.97M-5.58M-5.3M-20.21M
Net non-operating interest income expense -96.77%3.57K-58.14%9.71K2,754.26%309.03K110.33K23.2K10.83K
Non-operating interest income -92.51%8.65K-71.37%14.79K1,204.89%352.67K--115.39K--51.65K--27.03K
Non-operating interest expense 0.28%5.08K-82.16%5.08K169.39%43.64K--5.06K--28.45K--16.2K
Other net income (expense) -1,773.41%-940.34K-6,614.79%-332.52K-318.22%-79.82K-50.19K5.1K36.58K
Gain on sale of security -378.82%-240.34K-737.05%-32.52K-318.22%-79.82K---50.19K--5.1K--36.58K
Other non- operating income (expenses) ---700K---300K----------------
Income before tax -18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-5.52M-5.27M-20.16M
Income tax
Net income -18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-5.52M-5.27M-20.16M
Net income continuous Operations -18.97%-6.57M-57.41%-8.3M-22.74%-24.74M---5.52M---5.27M---20.16M
Minority interest income
Net income attributable to the parent company -18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-5.52M-5.27M-20.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-5.52M-5.27M-20.16M
Basic earnings per share 3.58%-0.3439-58.71%-0.54-23.05%-1.65-0.3566-0.3402-1.3409
Diluted earnings per share 3.58%-0.3439-58.71%-0.54-23.05%-1.65-0.3566-0.3402-1.3409
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data